Melanoma Institute Australia welcomes new CEO Matthew Browne

Melanoma Institute Australia welcomes new CEO Matthew Browne

9 August 2018

Melanoma Institute Australia is delighted to announce the appointment of Matthew Browne as Chief Executive Officer (CEO).

Matthew, who takes up the position effective immediately, brings to the organisation a wealth of experience in managing organisations involved in health care and major infrastructure projects.

He has been with Melanoma Institute Australia since January 2017, having performed the roles of Chief Financial Officer and Company Secretary, and more recently Acting CEO. Prior to joining Melanoma Institute Australia, Matthew was Acting CEO for Cure Brain Cancer Foundation and held a variety of senior executive roles responsible for Transport NSW’s Opal smartcard ticketing project, including  Director of Ticketing.

Matthew holds a Bachelor of Economics from Macquarie University and has been a member of the Institute of Chartered Accountants in Australia since 1990.

Chairman of Melanoma Institute Australia, Mr Grant King said; “We are excited to welcome Matthew as CEO of Melanoma Institute Australia as his leadership skills and experience in the medical research and not for profit sectors will ensure the organisation continues to be a world leader in melanoma prevention, treatment and cure.”

“Given Matthew’s previous executive roles, including at Melanoma Institute Australia, we are confident his transition into the CEO role will be smooth and effective and the organisation will continue its momentum towards its mission of zero deaths from melanoma,” he said.

“I am delighted and honoured to be leading such a world-class organisation,” Matthew Browne said. “I am proud of the achievements made by Melanoma Institute Australia over many years, providing patients with melanoma the very best standard of care and more life-saving treatment options.

“Melanoma Institute Australia is deeply committed to achieving its mission, and it will truly be a time to celebrate when that day arrives,” he said.

For more information, please contact:

Jennifer Durante |Melanoma Institute Australia | 0412 798 990 | jennifer.durante@melanoma.org.au

Saving our next generation
18 Nov 2014

Saving our next generation

Researcher James Wilmott is working to fill a gap in research for young patients.

It's time to march for a cure!
17 Nov 2014

It's time to march for a cure!

Join us for our fourth annual Melanoma March and help us raise over $1 million for melanoma research as we march for a cure! 

Making a difference
17 Nov 2014

Making a difference

When Melanoma Institute Australia (MIA) patients at the Poche Centre are first diagnosed with advanced melanoma Anna Hoadley is there.

New trial offers hope to Stage IV patients
17 Nov 2014

New trial offers hope to Stage IV patients

Shining new hope for patients with advanced stage melanoma.

Combination drug therapy halts disease in advanced melanoma
29 Sep 2014

Combination drug therapy halts disease in advanced melanoma

A world-first study in the New England Journal of Medicine heralds the effectiveness of a targeted combination drug therapy after reporting major declines in the risk of disease progression and death in people with metastatic melanoma.

Georgina Long wins award for Outstanding Cancer Research
22 Aug 2014

Georgina Long wins award for Outstanding Cancer Research

Associate Professor Georgina Long wins award for Cancer Institute NSW

Melanoma survivors walk from Sydney to Melbourne to raise money
26 Jul 2014

Melanoma survivors walk from Sydney to Melbourne to raise money

Melanoma survivors and long-time friends Jay Allen and Andrew Rust concluded their 900km walk from Sydney to Melbourne completing their walk at the Melbourne Cricket Ground on Saturday 26 July.

The Federal Government's 2015-16 Budget announcements benefit research

The Federal Government's 2015-16 Budget announcements benefit research

The Federal Government’s 2015-16 Budget was announced this week with a boost for medical research funding. 

Melanoma Essentials eBook offered for Free during EADO and GAC (PDF)

Melanoma Essentials eBook offered for Free during EADO and GAC

Sunrise features inspiring story of MIA patient

Sunrise features inspiring story of MIA patient

Melanoma Institute Australia (MIA) patient Tara Moran and her seven year old daughter Olivia, who is fundraising for MIA, have been in the national media spotlight this week. 

Dr James Wilmott wins award for Outstanding Cancer Research

Dr James Wilmott wins award for Outstanding Cancer Research

Dr James Wilmott was awarded the Wildfire Award at this year's Cancer Institute NSW's Premier Awards for Outstanding Cancer Research.

Cancer Australia releases 'stage at diagnosis' data for top five incidence cancers – including melanoma

Cancer Australia releases 'stage at diagnosis' data for top five incidence cancers – including melanoma

For the first time in Australia, national data has been released on cancer stage at diagnosis. This data explores the top five incidence cancers – female breast cancer, colorectal, lung, prostate cancers and melanoma.

All Aussies should have access to this lifesaver

All Aussies should have access to this lifesaver

Carrie Palmer writes for The Daily Telegraph about her experience with melanoma. 

15-year-old melanoma survivor Toby Rayner will lead Mount Gambier's march against melanoma

15-year-old melanoma survivor Toby Rayner will lead Mount Gambier's march against melanoma

Julie-Ann Sams knows all too well that melanoma doesn’t discriminate. Life changed for her
youngest son, Toby Rayner, when he was diagnosed with a rare from of iris melanoma that sadly required his left eye to be surgically removed.


 

15-year-old melanoma survivor Toby Rayner will lead Mount Gambier's march against melanoma

15-year-old melanoma survivor Toby Rayner will lead Mount Gambier's march against melanoma

Julie-Ann Sams knows all too well that melanoma doesn’t discriminate. Life changed for her
youngest son, Toby Rayner, when he was diagnosed with a rare from of iris melanoma that sadly required his left eye to be surgically removed.


 

Congratulations to our Conjoint Medical Directors

Congratulations to our Conjoint Medical Directors

Our Conjoint Medical Directors have been announced as Fellows of the Australian Academy of Health and Medical Sciences.

Melanoma diagnosis for Australian Survivor contestant stark warning about the risks of sun exposure

Melanoma diagnosis for Australian Survivor Contestant stark warning about the risks of sun exposure

News reports today of a recently evicted Australian Survivor star being diagnosed with melanoma should serve as a stark warning to all Australians of the serious health risks posed by sun exposure.

60 Minutes' MIA Patient Feature Program

60 Minutes' MIA Patient Feature Program

Five years ago Julie Randall was diagnosed with melanoma and was given months to live. The melanoma had spread throughout her body. The doctors said it was incurable and she’d be lucky if she survived the next nine months. Julie, a patient at Melanoma Institute Australia under Professor Georgina Long was placed on an experimental drug trial. To watch the entire program, visit 9now.com or click here

2019 Sun-Herald City2Surf
11 Aug 2019

2019 Sun-Herald City2Surf

Sydney, get your running shoes on! The City2Surf is coming and you're invited to become a join Team Melanoma!